The number of health problems continues to rise all around the globe. The majority of clinical issues are caused by diseased or damaged tissues and organs. Engineered constructs that contain cells, biomaterials, growth factors, peptides, and small molecules are widely employed in regenerative engineering to improve human condition. The ultimate goal is to repair or regenerate the damaged tissues. In this context, biomaterial-based approaches are highly promising strategies. The success of engineered biomaterials relies on the formation of 3D functional constructs with clinically relevant sizes.
Multidisciplinary topics from chemistry, biology, medicine, materials science, and engineering will be covered in this symposium by inviting keynote speakers from biomaterials and tissue engineering areas. The sessions will feature a wide range of biomaterials (e.g., hydrogels, fibers, proteins, lipids, synthetic polymers, elastomers, micro- nano-particles, ceramics, metals) for modulation of cell adhesion, proliferation, differentiation, or growth. Biomaterials with stimuli-responsive features will also be highlighted by the symposium. Furthermore, a wide spectrum of applications from development of artificial implants to materials for stem cell therapies will be emphasized. Clinical translation of engineered biomaterials will be presented by academic and industry partners. The discussions at this symposium will also facilitate major interactions between physicians, industry members and faculties from academic institutions to enhance the translation of tissue engineering information from bench to bed. The symposium will be of great importance to the materials community and biomedical industry and significantly contribute to interdisciplinary areas.